Clinical Trial Update: Pirfenidone: A New Drug to Treat Kidney Disease in Patients With Diabetes [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting Phase 1/2 testing of Pirfenidone for kidney disease in diabetes. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Nephropathy

Drugs mentioned

• PIRFENIDONE (pirfenidone)

Snippet

Sponsor: Sharma, Kumar, M.D. | Conditions: Diabetes Mellitus, Diabetic Nephropathy | Phase 1, Phase 2 | Status: COMPLETED